Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Pancreatic cancer remains one of the most lethal forms of cancer with a 10‐year survival of <1%. With little improvement in survival rates observed in the past 40years, there is a significant need for new treatments or more effective strategies to deliver existing treatments. The antimetabolite gemcitabine (Gem) is the most widely used form of chemotherapy for pancreatic cancer treatment, but is known to produce significant side effects when administered systemically. We have previously demonstrated the benefit of combined chemo‐sonodynamic therapy (SDT), delivered using oxygen carrying microbubbles (O2MB), as a targeted treatment for pancreatic cancer in a murine model of the disease. In this manuscript, we report the preparation of a biotin functionalised Gem ligand for attachment to O2MBs (O2MB‐Gem). We demonstrate the effectiveness of chemo‐sonodynamic therapy following ultrasound‐targeted‐microbubble‐destruction (UTMD) of the O2MB‐Gem and a Rose Bengal loaded O2MB (O2MB‐RB) as a targeted treatment for pancreatic cancer. Specifically, UTMD using the O2MB‐Gem and O2MB‐RB conjugates reduced the viability of MIA PaCa‐2, PANC‐1, BxPC3 and T110299 pancreatic cancer cells by >60% (p<0.001) and provided significant tumour growth delay (>80%, p<0.001) compared to untreated animals when human xenograft MIA PaCa‐2 tumours were treated in SCID mice. The toxicity of the O2MB‐Gem conjugate was also determined in healthy non‐tumour bearing MF1 mice and revealed no evidence of renal or hepatic damage. Therefore, the results presented in this manuscript suggest that chemo‐sonodynamic therapy using the O2MB‐Gem and O2MB‐RB conjugates, is potentially an effective targeted and safe treatment modality for pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00986-1 · Cited by 1,222 · cited 1×
“Many of the drug-based treatments for pancreatic cancer involve Gem either as a stand-alone agent or in combination with other chemotherapies / radiotherapy [4].”
BackgroundPhenotype and Genotype of Pancreatic Cancer Cell Lines
Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · cited 1×
“However, when oxygen levels rise, hydroxylation of HIF-1α prolines occurs and recognition by VHL results in HIF-1α degradation [26-28].”
BackgroundHypoxia-regulated target genes implicated in tumor metastasis
Tsai, Y.-P., & Wu, K.-J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-102 · Cited by 190
Cited by
Ultrasound‐Activated Sensitizers and Applications
Lin, X., Song, J., Chen, X., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201906823 · Cited by 501
Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery
Kooiman, K., Roovers, S., Langeveld, S. A. G., Kleven, R. T., Dewitte, H., O'Reilly, M. A., Escoffre, J.-M., Bouakaz, A., Verweij, M. D., Hynynen, K., et al. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.01.002 · Cited by 359
Self-citationAdvances and perspectives in organic sonosensitizers for sonodynamic therapy
Xing, X., Zhao, S., Xu, T., Huang, L., Zhang, Y., Lan, M., Lin, C., Zheng, X., & Wang, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214087 · Cited by 334
Activating Drugs with Sound: Mechanisms Behind Sonodynamic Therapy and the Role of Nanomedicine
Choi, V., Rajora, M. A., & Zheng, G. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00029 · Cited by 237
Yan, P., Liu, L.-H., & Wang, P. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00156 · Cited by 179
Metadata
- Authors
- Nesbitt, H., Sheng, Y., Kamila, S., Logan, K., Thomas, K., Callan, B., Taylor, M. A., Love, M., O'Rourke, D., Kelly, P., Beguin, E., Stride, E., McHale, A. P., & Callan, J. F.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 279
- Pages
- 8-16
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2797148094
- Cited by
- 108
- References
- 5
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. https://app.cochat.ai/papers/10.1016/j.jconrel.2018.04.018
- The paper
- Nesbitt, H., Sheng, Y., Kamila, S., Logan, K., Thomas, K., Callan, B., Taylor, M. A., Love, M., O'Rourke, D., Kelly, P., Beguin, E., Stride, E., McHale, A. P., & Callan, J. F. (2018). Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2018.04.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.